M. Ventimiglia

发表

Innate immune responses in patients treated with SBRT irradiation enhances prostate cancer remissions

A. Dritschilo, Y. Li, S. Suy, 2022, medRxiv.

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma

J. Abrams, A. Deol, J. Zonder, 2012, Journal of chemotherapy.

A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma

J. Abrams, A. Deol, L. Lum, 2010 .

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial

J. Abrams, L. Lum, V. Ratanatharathorn, 2012, Supportive Care in Cancer.

A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

J. Abrams, A. Deol, J. Zonder, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

A. Deol, L. Lum, V. Ratanatharathorn, 2015, Bone Marrow Transplantation.

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

A. Deol, J. Uberti, V. Ratanatharathorn, 2017, Bone Marrow Transplantation.

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Nadine H Abdallah, A. Deol, Seongho Kim, 2018, Bone Marrow Transplantation.

J. Abrams, A. Deol, J. Zonder, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.